Research programme: melanoma vaccine - Henderson Morley
Latest Information Update: 30 May 2011
At a glance
- Originator Henderson Morley
- Class Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Malignant melanoma
Most Recent Events
- 03 Aug 2009 Preclinical trials in Malignant melanoma in United Kingdom (Parenteral)